Goals for Reaching Optimal Wellness (GROWell): A clinical trial protocol of a digital dietary intervention for pregnant and postpartum people with prenatal overweight or obesity.
Goals for Reaching Optimal Wellness (GROWell): A clinical trial protocol of a digital dietary intervention for pregnant and postpartum people with prenatal overweight or obesity.
复制标题
DOI：
10.1016/j.cct.2021.106627
复制
发表时间：
2022-03
影响因子：
2.2
通讯作者：
Noonan, Devon
中科院分区：
文献类型：
--
作者：
Simmons, Leigh Ann;Phipps, Jennifer E.;Overstreet, Courtney;Smith, Paige M.;Bechard, Elizabeth;Liu, Siwei;Walker, Cheryl;Noonan, Devon
关键词：
妊娠期体重增加过多 (EGWG) 与多种妊娠并发症以及分娩者及其婴儿的健康风险有关。同样，产后体重保留（PPWR），或者说没有减掉所有孕期体重，也会对健康产生长期影响。与符合医学研究所指南的女性相比，超重或肥胖怀孕的 EGWG 产科结果更差，PPWR 增加。本研究方案描述了 GROWell 的盲法随机临床试验的细节：达到最佳健康的目标，这是一种移动健康工具，旨在改善体重超重或肥胖的怀孕人群的饮食质量，帮助他们实现适当的 GWG 和安全的产后妊娠减肥。超重和肥胖的个体将被随机分配到注意力控制组或干预组。干预组将收到有关饮食选择的个性化、以目标为导向的短信，而注意力对照组将收到有关健康怀孕、临产、分娩和婴儿早期的短信。两组都将在基线、随访、产后 3 个月和 6 个月时完成在线调查。目前，已招收162名受试者。与 GWG 和妊娠相关的结果预计将在 2023 年底获得，而产后体重保留 GROWell 依从性的结果预计将在 2024 年底获得。该试验的结果将支持使用基于证据的 mHealth 工具整合到临床实践中，以减少超重和肥胖 BMI 孕妇的 EGWG 和 PPWR，这是目前缺乏的资源。 ClinicalTrials.gov 标识符：NCT04449432。 2020年6月26日注册。
Excess gestational weight gain (EGWG) is associated with multiple pregnancy complications and health risks for birthing people and their infants. Likewise, postpartum weight retention (PPWR), or not losing all pregnancy weight, has long-term health consequences. EGWG among people who enter pregnancy with overweight or obesity have worse obstetric outcomes and increased PPWR compared to women who gain within Institute of Medicine guidelines. This study protocol describes the details of a blinded, randomized clinical trial of GROWell: Goals for Reaching Optimal Wellness, a mHealth tool designed to improve diet quality among people who enter pregnancy with overweight or obese BMIs to help them achieve appropriate GWG and safe postpartum pregnancy weight loss. Individuals with overweight and obesity will be randomly assigned to an attention control or intervention arm. The intervention group will receive personalized, goal-oriented text messages regarding dietary choices, while the attention control group will receive text messages about healthy pregnancy, labor, delivery, and early infancy. Both groups will complete online surveys at baseline, follow up, 3 and 6 months postpartum. Currently, 162 subjects have been enrolled. Outcomes associated with GWG and pregnancy are expected in late 2023, while outcomes on postpartum weight retention GROWell adherence are expected in late 2024. The results of this trial will support the use of an evidence-based mHealth tool to be integrated into clinical practice to reduce EGWG and PPWR among pregnant people with overweight and obese BMIs, a resource that is currently lacking. ClinicalTrials.gov identifier: NCT04449432. Registered on June 26, 2020.
登录
查看更多内容
影响因子：
3.1
作者：
Olander EK;Berg M;McCourt C;Carlström E;Dencker A
通讯作者：
Dencker A
影响因子：
7.2
作者：
Bogaerts, Annick;Van den Bergh, Bea R. H.;Devlieger, Roland
通讯作者：
Devlieger, Roland
影响因子：
4.9
作者：
Ferrara, CM;Kumar, M;Goldberg, AP
通讯作者：
Goldberg, AP
影响因子：
4.5
作者：
Edvardsson, Kristina;Ivarsson, Anneli;Mogren, Ingrid
通讯作者：
Mogren, Ingrid
DOI：
10.1097/00005768-200007000-00022
发表时间：
2000-07-01
期刊：
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE
影响因子：
--
作者：
Ainsworth, BE;Sternfeld, B;Jackson, K
通讯作者：
Jackson, K